| Date Filed | Type | Description |
| 06/16/2023 |
4
| Meyers Michael L. (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/03/2022 |
4
| Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Exercised 5,900 options to buy
@ $8.77, valued at
$51.7k
|
|
| 04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2019 |
4/A
| Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Bought 8 shares
@ $4.87, valued at
$39 |
|
| 03/22/2019 |
4
| Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Bought 1,000 shares
@ $4.93, valued at
$4.9k
Bought 104 shares
@ $4.87, valued at
$506.5 |
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2018 |
4
| Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Bought 200 shares
@ $4.79, valued at
$958 |
|
| 03/05/2018 |
4
| Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 75,000 options to buy
@ $9.4, valued at
$705k
|
|
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |